Wynn Capital’s Bristol-Myers Squibb BMY Stock Holding History

Wynn Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,875	Closed	-$236K	–	111
2025 Q1	$236K	Hold	3,875	–	–	0.14%	102
2024 Q4	$219K	Hold	3,875	–	–	0.14%	103
2024 Q3	$200K	Buy	+3,875	New	+$182K	0.13%	106
2024 Q2	–	Sell	-4,475	Closed	-$243K	–	103
2024 Q1	$243K	Sell	4,475 -50	-1%	-$2.55K	0.19%	93
2023 Q4	$232K	Buy	+4,525	New	+$238K	0.19%	94

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wynn Capital's BMY Position: Q2 2025 in Review

Wynn Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,875 shares — an estimated $236K sold.

Wynn Capital first reported a position in BMY in Q4 2023 and held it in 5 quarters. The position peaked at $243K in Q1 2024. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Wynn Capital reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Wynn Capital sold 3,875 Bristol-Myers Squibb shares in Q2 2025, an estimated $236K.
Wynn Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 5 quarters.
Wynn Capital's Bristol-Myers Squibb position peaked at $243K in Q1 2024.
2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Wynn Capital's 13F filing for Q2 2025, filed 22 Jul 2025.